Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.3K
Asthma-I: Introduction01:29

Asthma-I: Introduction

3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma.

Allergy·2026
Same author

Neonatal Intensive Care Unit Nurses' End-of-Life Care Experience: Becoming a More Empathetic Professional Caregiver.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses·2026
Same author

EAACI Guidelines on Environmental Science for Allergy and Asthma-Evidence-Based Recommendations for Prevention and Public Health Action to Mitigate the Impact of Pollen Exposure on Respiratory Allergy.

Allergy·2026
Same author

Characteristics and management of asthma from the China Asthma Data Registry Project.

ERJ open research·2026
Same author

Clinical Features of Cellular Senescence Pathways in Severe Asthma.

Allergy·2026
Same author

Phenomenological insights into disclosure and concealment decision-making among people with epilepsy experiencing generalized tonic-clonic seizures.

Japan journal of nursing science : JJNS·2026
Same journal

Allergenic Characterization of Parvalbumin, Tric l 1, From Atlantic cutlassfish, <i>Trichiurus lepturus</i>.

Allergy, asthma & immunology research·2026
Same journal

Increased Levels of Serum Eosinophil-Derived Neurotoxin in Patients With Chronic Spontaneous Urticaria.

Allergy, asthma & immunology research·2026
Same journal

Serum Neuropeptides in Chronic Spontaneous Urticaria: Associations With Disease Activity and Clinical Phenotypes.

Allergy, asthma & immunology research·2026
Same journal

Real-World Efficacy and Safety of Upadacitinib in Korean Patients With Atopic Dermatitis.

Allergy, asthma & immunology research·2026
Same journal

Prevalence of Immediate-Type Food Allergy and Food-Induced Anaphylaxis in Korean Schoolchildren.

Allergy, asthma & immunology research·2026
Same journal

Efficacy and Adherence of Combined Fluticasone Propionate and Azelastine Nasal Spray Versus Fluticasone Propionate Alone in Pediatric Allergic Rhinitis.

Allergy, asthma & immunology research·2026
See all related articles

Related Experiment Video

Updated: Jan 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K

Future Risks in Patients With Severe Asthma.

Woo Jung Song1, Ji Hyang Lee2, Yewon Kang3

  • 1Department of Allergy and Clinical Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. swj0126@amc.seoul.kr.

Allergy, Asthma & Immunology Research
|September 26, 2019
PubMed
Summary
This summary is machine-generated.

Severe asthma patients face risks like lung function decline and medication side effects. Current tools fail to predict these future health burdens, even in controlled cases.

Keywords:
Asthmariskseverity

More Related Videos

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Related Experiment Videos

Last Updated: Jan 19, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells
04:56

In Vitro Method to Control Concentrations of Halogenated Gases in Cultured Alveolar Epithelial Cells

Published on: October 23, 2018

7.0K
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Area of Science:

  • Pulmonology
  • Clinical Medicine
  • Pharmacology

Background:

  • Severe asthma presents a significant burden due to risks of exacerbations, lung function decline, and medication side effects, particularly oral corticosteroids (OCSs).
  • Current clinical tools inadequately measure or predict future adverse health outcomes and medication-related morbidity in severe asthma patients.
  • The future risk associated with severe asthma is often underestimated, especially in patients whose asthma is considered controlled.

Purpose of the Study:

  • To review current evidence on the future risks faced by patients with severe asthma.
  • To focus on the risks in 'controlled' severe asthma, where future progression and OCS side effects may be poorly perceived.
  • To highlight the need for novel therapeutic strategies that mitigate future risks without compromising asthma control.

Main Methods:

  • Literature review of existing evidence on future health risks in severe asthma.
  • Analysis of data concerning lung function decline and OCS-related morbidity.
  • Examination of the predictive limitations of current asthma control and quality-of-life assessment tools.

Main Results:

  • Long-term oral corticosteroid (OCS) therapy may not prevent future asthma progression, including lung function decline.
  • The risk of adverse drug side effects from OCSs increases, even at low doses.
  • Existing measures of asthma control and quality of life do not reliably predict future medication-related morbidity.

Conclusions:

  • There is a critical need for better methods to assess and manage future risks in severe asthma.
  • Novel treatments are essential to reduce long-term adverse outcomes and OCS side effects in severe asthma patients.
  • Reducing future risks in severe asthma is crucial, even when asthma control appears adequate.